Clinical Trials Browser

Phase EARLY_PHASE1 × AZD1390 × 90 days × Clear all

NCT05182905 2026-03-09

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Phase EARLY_PHASE1 Active not recruiting

Glioblastoma, Glioma